Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang-In Lin

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Plos One|February 8, 2014
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patientsYu-Lin Lin, Yi-Hsin Liang, Jia-Huei Tsai, et al.
Cancer Research|March 17, 2006
Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolutionWen-Chien Chou, Jih-Luh Tang, Liang-In Lin, et al.
Molecular Cancer Research : MCR|May 9, 2022
Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic LeukemiaJung-Lin Wu, Hsin-Yi Wu, Shang-Ju Wu, et al.
Blood Cancer Journal|April 6, 2018
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndromeHsin-An Hou, Cheng-Hong Tsai, Chien-Chin Lin, et al.
Cancer Research|December 6, 2014
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasisPei-Chun Wu, Jeng-Wei Lu, Jer-Yen Yang, et al.
Ebiomedicine|January 22, 2019
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patientsCheng-Hong Tsai, Chi-Yuan Yao, Feng-Min Tien, et al.
Blood Advances|May 17, 2021
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AMLCheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, et al.
Blood|October 8, 2009
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterationsJih-Luh Tang, Hsin-An Hou, Chien-Yuan Chen, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
Blood|April 7, 2010
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring systemHsin-An Hou, Tai-Chung Huang, Liang-In Lin, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Plos One|February 8, 2014
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patientsYu-Lin Lin, Yi-Hsin Liang, Jia-Huei Tsai, et al.
Cancer Research|March 17, 2006
Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolutionWen-Chien Chou, Jih-Luh Tang, Liang-In Lin, et al.
Molecular Cancer Research : MCR|May 9, 2022
Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic LeukemiaJung-Lin Wu, Hsin-Yi Wu, Shang-Ju Wu, et al.
Blood Cancer Journal|April 6, 2018
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndromeHsin-An Hou, Cheng-Hong Tsai, Chien-Chin Lin, et al.
Cancer Research|December 6, 2014
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasisPei-Chun Wu, Jeng-Wei Lu, Jer-Yen Yang, et al.
Ebiomedicine|January 22, 2019
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patientsCheng-Hong Tsai, Chi-Yuan Yao, Feng-Min Tien, et al.
Blood Advances|May 17, 2021
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AMLCheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, et al.
Blood|October 8, 2009
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterationsJih-Luh Tang, Hsin-An Hou, Chien-Yuan Chen, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
Blood|April 7, 2010
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring systemHsin-An Hou, Tai-Chung Huang, Liang-In Lin, et al.
Pageof 9